Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Anesteziol Reanimatol ; (1): 69-72, 2011.
Article in Russian | MEDLINE | ID: mdl-21510069

ABSTRACT

The purpose of the study is to examine the efficacy and safety through the introduction of a local anesthetic wound irrigation catheter for continuous postoperative analgesia in newborns. The study was conducted during the postoperative period of 33 full-term newborns. In the study group (n = 15), analgesia was carried out through the wound catheter with infusion of local anesthetic, for the control group (n = 18) continuous intravenous infusion promedol was used. The effectiveness of postoperative analgesia was rated by CRIES postoperative pain control scale, monitoring of skin conductance, cardiointervalogram and hormone level control in the blood. The study showed that the use of wound catheter for continuous postoperative analgesia with local anesthetics provides effective level of analgesia in newborns, which is comparable with the introduction of opioid analgesics. There were no severe postoperative complications. The method of analgesia by administering a local anesthetic through the wound catheter can be recommended for postoperative analgesia in newborns, especially during major surgeries.


Subject(s)
Anesthesiology/methods , Critical Care/methods , Galvanic Skin Response/physiology , Monitoring, Physiologic/methods , Humans , Pain Measurement/methods
2.
Article in Russian | MEDLINE | ID: mdl-21350408

ABSTRACT

This work was conducted in the frames of a multicenter clinical trial. The aim was to study efficacy of cytoflavin (infusion solution) in the prevention and treatment of posthypoxic CNS lesions in premature newborns. The study included 120 premature newborns (gestation period 28-36 weeks) who was born in severe distress and needed the intensive therapy after primary reanimation measures. Cytoflavin was prescribed in the first 2-4 h after the delivery to 61 newborns. The control group included 59 newborns who did not receive the drug. To assess treatment efficacy, the determination of some plasma neurospecific proteins (GFAP, NSE, MBP) was carried out along with standard clinical/instrumental and laboratory monitoring. The results revealed the marked cerebroprotective effect of cytoflavin. The significantly higher rate of normalization of KOC, pO2, PCO2 and elimination of lactate acidosis that led to the reduction of severity and frequency of ischemic and hemorrhagic CNS lesions as well as lower levels of plasma neurospecific proteins were seen in the main group compared to the control one.


Subject(s)
Fetal Hypoxia/complications , Flavin Mononucleotide/administration & dosage , Hypoxia-Ischemia, Brain/prevention & control , Inosine Diphosphate/administration & dosage , Intensive Care, Neonatal/methods , Niacinamide/administration & dosage , Resuscitation/methods , Succinates/administration & dosage , Drug Combinations , Female , Fetal Hypoxia/blood , Glial Fibrillary Acidic Protein/blood , Humans , Hypoxia-Ischemia, Brain/blood , Hypoxia-Ischemia, Brain/etiology , Infant, Newborn , Intensive Care Units, Neonatal , Male , Myelin Basic Protein/blood , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL